transcend semaglutide Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Oral Semaglutide for Weight Loss

During calorie restriction (cutting), more protein is needed to prevent muscle loss (as discussed in the weight loss section)

In their paper on the study, published in JAMA Ophthalmology , the researchers noted that the substantially increased risk of NAION observed in patients on semaglutide appears not to be due to differences in baseline characteristics between the cohorts. They proposed the possibility that expression of the GLP-1 receptor in the human optic nerve and GLP-1 RA-induced enhanced sympathetic nervous system activity might influence optic nerve head perfusion and potentially increase the risk of NAION. Another notable finding was that the greatest risk of NAION appeared to be within the first year following the prescription of semaglutide, a temporal association that supports a potential drug-induced risk of NAION, the researchers pointed out

But hidden within those basic steps are dozens of opportunities to damage or degrade the copper peptide complex before it ever reaches your skin or tissue

However, if frequent urination is accompanied by burning, urgency, or changes in urine appearance, it may indicate infection rather than simple fluid balance

Semaglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated neuroprotective potential